The UK private general practitioner electronic health record (GP EHR) market is set to grow, driven by increasing demand for private medical care, advancements in healthcare tech, and the need for secure patient data storage. Search for private GPs in the UK surged 156% between 2019 and 2022. Limitations such as privacy concerns and technical issues could, however, hinder the sector’s growth.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
